![A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis - Hotta - 2019 - Journal of Diabetes Investigation - Wiley Online Library A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis - Hotta - 2019 - Journal of Diabetes Investigation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5bb41d99-ee15-4164-801f-97677d98d817/jdi13090-fig-0001-m.jpg)
A new perspective on the biguanide, metformin therapy in type 2 diabetes and lactic acidosis - Hotta - 2019 - Journal of Diabetes Investigation - Wiley Online Library
![Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions | Semantic Scholar Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b9ee1c015047c46d17d77fb95015ed1924fd2e2d/8-Figure3-1.png)
Mechanisms of action of metformin in type 2 diabetes: Effects on mitochondria and leukocyte-endothelium interactions | Semantic Scholar
![Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial - The Lancet Diabetes & Endocrinology Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial - The Lancet Diabetes & Endocrinology](https://www.thelancet.com/cms/attachment/2116720242/2085077274/gr1.gif)
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial - The Lancet Diabetes & Endocrinology
![Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity? - Media Centre | EASD Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity? - Media Centre | EASD](https://d2t0unnjxes6lt.cloudfront.net/data/easd/data/talks/546_706110/Slide4.jpg)
Mechanism of increase in plasma intact GLP-1 by metformin in type 2 diabetes: stimulation of GLP-1 secretion or reduction in plasma DPP-4 activity? - Media Centre | EASD
![Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus | Cardiovascular Diabetology | Full Text Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus | Cardiovascular Diabetology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12933-020-01202-5/MediaObjects/12933_2020_1202_Fig1_HTML.png)
Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus | Cardiovascular Diabetology | Full Text
![Men's use of diabetes drug just before conception is linked to a 40% increase in birth defects, study finds | CNN Men's use of diabetes drug just before conception is linked to a 40% increase in birth defects, study finds | CNN](https://media.cnn.com/api/v1/images/stellar/prod/160324161342-fda-black-box-drugs-metformin.jpg?c=16x9&q=h_270,w_480,c_fill)
Men's use of diabetes drug just before conception is linked to a 40% increase in birth defects, study finds | CNN
![URSPRUNG DES WUNDERMITTELS SYNERGISMUS VON METFORMIN UND NATRIUMBUTYRAT. - PCP Pharma S.A. Deutschland URSPRUNG DES WUNDERMITTELS SYNERGISMUS VON METFORMIN UND NATRIUMBUTYRAT. - PCP Pharma S.A. Deutschland](https://pcppharma.de/wp-content/uploads/2022/02/abbildung1.jpg)
URSPRUNG DES WUNDERMITTELS SYNERGISMUS VON METFORMIN UND NATRIUMBUTYRAT. - PCP Pharma S.A. Deutschland
![Istanbul, Türkei - 12. Dezember 2022; glucophage (Metformin), ein Medikament zur Behandlung von Typ-2-Diabetes. Schachtel mit 1000 mg Stockfotografie - Alamy Istanbul, Türkei - 12. Dezember 2022; glucophage (Metformin), ein Medikament zur Behandlung von Typ-2-Diabetes. Schachtel mit 1000 mg Stockfotografie - Alamy](https://l450v.alamy.com/450vde/2heryd6/istanbul-turkei-12-dezember-2022-glucophage-metformin-ein-medikament-zur-behandlung-von-typ-2-diabetes-schachtel-mit-1000-mg-2heryd6.jpg)